References

1. Pui CH, Evans WE: Acute lymphoblastic leukemia. N Engl J Med 339:605, 1998.

2. Copelan EA, McGuire EA: The biology and treatment of acute lymphoblastic leukemia in adults. Blood 85:1151, 1995.

3. Lamanna N, Weiss M: Treatment options for newly diagnosed patients with adult acute lymphoblastic leukemia. Curr Hematol Rep 3(1):40-46, 2004.

4. Hoelzer D, Thiel E, Loffler H, et al.: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123, 1988.

5. Gaynor J, Chapman D, Little C, et al.: A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969. J Clin Oncol 6:1014, 1988.

6. Boucheix C, David B, Sebban C, et al.: Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). Blood 84:1603, 1994.

7. Hoelzer D, Ludwig WD, Thiel E, et al.: Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 87:495, 1996.

8. Thomas DA, Cortes J, O'Brien S, et al.: Hyper-CVAD program in Burkitt's type adult lymphoblastic leukemia. J Clin Oncol 17:2461, 1999.

9a. Barrett AJ, Horowitz MM, Ash RC, et al.: Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 79:3067, 1992.

9b. Wetzler M, Dodge RK, Mrozek K, et al.: Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B Experience. Blood 93(11):3983, 1999.

9c. Secker-Walker LM, Prentice HG, Durrant J, et al.: On behalf of the MRC Adult Leukemia Working Party: Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukemia on MRC trial UKALLXA. Br J Haematol 96:601, 1997.

10. Woodruff R, Lister T, Paxton A, et al.: Combination chemotherapy for hematologic relapse in adult acute lym-phoblastic leukemia (ALL). Am J Hematol 4:173-177, 1978.

11. Capizzi RI, Poole M, Cooper MR, et al.: Treatment of poor risk acute leukemia with sequential high-dose Ara-C and asparaginase. Blood 63:694, 1984.

12. Amadori S, Papa F, Avvisati G, et al.: Sequential combination high-dose Ara-C and asparaginase for the treatment of advanced acute leukemia and lymphoma. Leuk Res 8:729, 1984.

13. Wells RJ, Feusner J, Devney R, et al.: Sequential highdose cytosine arabinoside-asparaginase treatment in advance childhood leukemia. J Clin Oncol 3:998, 1985.

patients we favor high-dose cytarabine with high-dose anthracycline) followed by an allogeneic transplant.

0 0

Post a comment